Kinnate Biopharma Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Kinnate Biopharma Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2020 to Q4 2023.
  • Kinnate Biopharma Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2023 was $2.24M, a 99.9% increase year-over-year.
  • Kinnate Biopharma Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2023 was $8.53M, a 279% increase year-over-year.
  • Kinnate Biopharma Inc. annual Nonoperating Income (Expense) for 2023 was $8.53M, a 279% increase from 2022.
  • Kinnate Biopharma Inc. annual Nonoperating Income (Expense) for 2022 was $2.25M, a 547% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $8.53M $2.24M +$1.12M +99.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $7.41M $2.36M +$1.72M +271% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $5.69M $2.22M +$1.88M +558% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $3.81M $1.71M +$1.56M +991% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $2.25M $1.12M +$1.02M +1021% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $1.23M $635K +$535K +535% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $694K $337K +$213K +172% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $481K $157K +$133K +554% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $348K $100K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 $100K +$96K +2400% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $124K +$112K +933% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $24K -$188K -88.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 $4K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $12K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $212K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.